Dorian Burkhalter

This content was published on

September 9, 2026 – 15:00

Dear reader,

Last week in Geneva, the Group of Governmental Experts of the Convention on Certain Conventional Weapons concluded three years of work on the burning issue of “killer robots”. After heated discussions, the 128 member states of the Convention managed to agree on a definition of these weapons and to establish certain basic principles.

Autonomous weapons capable of targeting people without human intervention have been a concern for several years at the United Nations and the Red Cross (ICRC), which have been calling for their regulation. According to them, these systems may not be able to distinguish, in real time, between a combatant and a person protected by international humanitarian law, such as a wounded soldier.

Last month, at a press conference at the Palais des Nations, the UN and the ICRC could not confirm whether such weapons had ever been used. Some media outlets have reported cases of Ukrainian drones boosted with artificial intelligence, and the United States has reportedly used AI to identify targets in the Middle East, but this does not rule out human control. What is certain is that the development of these weapons is underway and that their deployment on the battlefields is only a matter of time.

All eyes are now on the next review conference of the Convention, which takes place every five years and will be held at the end of November in Geneva. Countries will then have the opportunity to open real negotiations on a future international treaty governing these weapons. Will they do so? How far will they be willing to go? Will they agree to introduce bans? The question remains open.

The issue goes beyond killer robots alone. Several humanitarian disarmament treaties have faced setbacks in recent years, notably with the withdrawal of several countries from the convention banning anti-personnel mines. In this context, the opening of talks would send a strong signal that despite geopolitical tensions, it is still possible to agree on rules limiting certain weapons.

We’ll find out in November.

Are there any particular themes that interest you that you would like us to explore? You can write to me at: dorianvalere.burkhalter@swissinfo.ch

Best regards,
Dorian Burkhalter

P.S. If you find the newsletter useful, please feel free to forward it to others – you can subscribe here.

The latest articles on geopolitics

Photo of woman

More

International Geneva

UN agency’s mass layoffs leave developing countries struggling to repay debt

This content was published on

Sep 7, 2026

UN and foreign aid budget cuts are having long-lasting impact on people’s lives.

Read more: UN agency’s mass layoffs leave developing countries struggling to repay debt

The city of Geneva is host to 40 international institutions, organisations, bodies as well the UN's European headquarters, 750 NGOs and the permanent representations of 185 member states, including Switzerland.

More

International Geneva

Rival cities vie to ‘poach’ international organisations from Geneva

This content was published on

Sep 7, 2026

Trump aid cuts prompt European and Gulf capitals to try to lure away UN bodies and NGOs.

Read more: Rival cities vie to ‘poach’ international organisations from Geneva

Opinion

More

Trade policy

As a maritime power, Switzerland has a responsibility when it comes to shipbreaking

This content was published on

Sep 4, 2026

Every year, hundreds of ships are scrapped with little consideration for workers and the environment.

Read more: As a maritime power, Switzerland has a responsibility when it comes to shipbreaking

Person using Temu service

More

Best of SRG content

Chinese retail platform Temu challenges consumers and retailers

This content was published on

Sep 4, 2026

Temu’s expansion drive could come at expense of Swiss consumers and retailers, says trade group.

Read more: Chinese retail platform Temu challenges consumers and retailers

researcher

More

Healthcare innovation

China’s pharma companies turn to Europe for growth

This content was published on

Sep 3, 2026

China has become a pharma powerhouse, but local firms still face a steep climb toward financial stability and global growth.

Read more: China’s pharma companies turn to Europe for growth

Click here for our overview page on geopolitics.